Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
N.S. Nurmohamed, G.M. Dallinga – Thie & E.S.G. Stroes. (2020) Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia. Expert Review of Cardiovascular Therapy 18:6, pages 355-361.
Read now
Read now
Jose G Jimenez-Montero & Gregory Haft. (2015) Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence. Research and Reports in Endocrine Disorders 5, pages 1-13.
Read now
Read now
Laia Salvadó, Lucía Serrano-Marco, Emma Barroso, Xavier Palomer & Manuel Vázquez-Carrera. (2012) Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus. Expert Opinion on Therapeutic Targets 16:2, pages 209-223.
Read now
Read now
David R Janero, Loren Lindsley, Venkata Kiran Vemuri & Alexandros Makriyannis. (2011) Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk. Expert Opinion on Drug Discovery 6:10, pages 995-1025.
Read now
Read now
Gerald F Watts & Fredrik Karpe. (2011) Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?. Expert Review of Cardiovascular Therapy 9:8, pages 987-997.
Read now
Read now
Altan Onat. (2011) Metabolic syndrome: nature, therapeutic solutions and options. Expert Opinion on Pharmacotherapy 12:12, pages 1887-1900.
Read now
Read now
Articles from other publishers (43)
Nick S.R. Lan, Kharis Burns, Damon A. Bell & Gerald F. Watts. (2021) Best practice for treating dyslipidaemia in patients with diabetes based on current international guidelines. Current Opinion in Endocrinology, Diabetes & Obesity 28:2, pages 104-113.
Crossref
Crossref
Darya S. Seryogina, Igor P. Nikolayenkov & Tatyana U. Kuzminykh. (2020) Obesity represents a strong pathogenetic link with the pathology of pregnancy and childbirth. Journal of obstetrics and women's diseases 69:2, pages 73-82.
Crossref
Crossref
О. А. Бурка, М. І. Бобрик, В. М. Резниченко & Т. М. Тутченко. (2019) Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women. Reproductive Endocrinology 0:47, pages 35-42.
Crossref
Crossref
Aruna D. Pradhan, Nina P. Paynter, Brendan M. Everett, Robert J. Glynn, Pierre Amarenco, Marshall Elam, Henry Ginsberg, William R. Hiatt, Shun Ishibashi, Wolfgang Koenig, Børge G. Nordestgaard, Jean-Charles Fruchart, Peter Libby & Paul M Ridker. (2018) Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. American Heart Journal 206, pages 80-93.
Crossref
Crossref
Philip L.S.M. Gordts & Jeffrey D. Esko. (2018) The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis. Matrix Biology 71-72, pages 262-282.
Crossref
Crossref
Adam J. Nelson & Stephen J. Nicholls. (2018) Treating Dyslipidemia in Type 2 Diabetes. Cardiology Clinics 36:2, pages 233-239.
Crossref
Crossref
Adam J. Nelson, Simon K. Rochelau & Stephen J. Nicholls. (2018) Managing Dyslipidemia in Type 2 Diabetes. Endocrinology and Metabolism Clinics of North America 47:1, pages 153-173.
Crossref
Crossref
Miguel Aguirre, Yajaira Briceño, Roald Gómez-Pérez, Yajaira Zerpa, Nolis Camacho & Mariela Paoli. (2018) Relación triglicéridos/colesterol de la lipoproteína de alta densidad como indicador de riesgo cardiometabólico en niños y adolescentes de la ciudad de Mérida, Venezuela. Endocrinología, Diabetes y Nutrición 65:2, pages 74-83.
Crossref
Crossref
Miguel Aguirre, Yajaira Briceño, Roald Gómez-Pérez, Yajaira Zerpa, Nolis Camacho & Mariela Paoli. (2018) Triglycerides/High density lipoprotein cholesterol ratio as a cardiometabolic risk marker in children and adolescents from Mérida city, Venezuela. Endocrinología, Diabetes y Nutrición (English ed.) 65:2, pages 74-83.
Crossref
Crossref
Chee Hae Kim, Kyung Ah Han, Jaemyung Yu, Sang Hak Lee, Hui Kyung Jeon, Sang Hyun Kim, Seok Yeon Kim, Ki Hoon Han, Kyungheon Won, Dong-Bin Kim, Kwang-Jae Lee, Kyungwan Min, Dong Won Byun, Sang-Wook Lim, Chul Woo Ahn, SeongHwan Kim, Young Joon Hong, Jidong Sung, Seung-Ho Hur, Soon Jun Hong, Hong-Seok Lim, Ie Byung Park, In Joo Kim, Hyoungwoo Lee & Hyo-Soo Kim. (2018) Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial. Clinical Therapeutics 40:1, pages 83-94.
Crossref
Crossref
Štefan Tóth, Matej Šajty, Tímea Pekárová, Adil Mughees, Peter Štefanič, Matan Katz, Katarína Spišáková, Jozef Pella & Daniel Pella. (2017) Addition of omega-3 fatty acid and coenzyme Q10 to statin therapy in patients with combined dyslipidemia. Journal of Basic and Clinical Physiology and Pharmacology 28:4, pages 327-336.
Crossref
Crossref
A. Palomäki, V. Hällberg, M. Ala-Korpela, P. T. Kovanen & K. Malminiemi. (2016) Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital. Lipids in Health and Disease 15:1.
Crossref
Crossref
H.-S. Kim, H. Kim, Y. J. Jeong, S. J. Yang, S. J. Baik, H. Lee, S.-H. Lee, J. H. Cho, I.-Y. Choi, H. W. Yim & K.-H. Yoon. (2016) Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea. Journal of Clinical Pharmacy and Therapeutics 41:5, pages 508-514.
Crossref
Crossref
D. John Betteridge & Rafael Carmena. (2015) The diabetogenic action of statins — mechanisms and clinical implications. Nature Reviews Endocrinology 12:2, pages 99-110.
Crossref
Crossref
Fatima Al Hannan & Kevin Gerard Culligan. (2015) Human resistin and the RELM of Inflammation in diabesity. Diabetology & Metabolic Syndrome 7:1.
Crossref
Crossref
Jeffrey B. Rosen, Christie M. Ballantyne, Willa A. Hsueh, Jianxin Lin, Arvind K. Shah, Robert S. Lowe & Andrew M. Tershakovec. (2015) Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk. Lipids in Health and Disease 14:1.
Crossref
Crossref
Anna Montali, Gessica Truglio, Francesco Martino, Fabrizio Ceci, Giampiero Ferraguti, Ester Ciociola, Marianna Maranghi, Francesco Gianfagna, Licia Iacoviello, Roberto Strom, Marco Lucarelli & Marcello Arca. (2015) Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects. PLOS ONE 10:4, pages e0120099.
Crossref
Crossref
Lorenzo Arnaboldi & Alberto Corsini. (2015) Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. Atherosclerosis Supplements 16, pages 1-27.
Crossref
Crossref
Marcello Arca. 2015. Multidisciplinary Approach to Obesity. Multidisciplinary Approach to Obesity
121
130
.
Henna Cederberg & Markku Laakso. 2015. Dyslipidemias. Dyslipidemias
99
113
.
T. W. K. Ng, E. M. M. Ooi, G. F. Watts, D. C. Chan & P. H. R. Barrett. (2014) Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men. Diabetes, Obesity and Metabolism 16:6, pages 519-526.
Crossref
Crossref
James L. Wilson. (2014) Clinical perspective on stress, cortisol and adrenal fatigue. Advances in Integrative Medicine 1:2, pages 93-96.
Crossref
Crossref
WenWen Li, QuanHui Wang, JianJun Chen, Jian Zhou, XinYu Zhou & Peng Xie. (2013) A multiple-reaction-monitoring mass spectrometric method for simultaneous quantitative analysis of five plasma apolipoproteins. Science China Chemistry 57:5, pages 723-731.
Crossref
Crossref
Sandra J. Hamilton & Gerald F. Watts. 2014. Lipoproteins in Diabetes Mellitus. Lipoproteins in Diabetes Mellitus
239
278
.
Jenq-Wen Huang, Chung-Yi Yang, Hon-Yen Wu, Kao-Lang Liu, Chi-Ting Su, Cho-Kai Wu, Jen-Kuang Lee, Chih-Kang Chiang, Hui-Teng Cheng, Yu-Chung Lien & Kuan-Yu Hung. (2013) Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients. Cardiovascular Diabetology 12:1.
Crossref
Crossref
Gerald F. Watts, Esther M. M. Ooi & Dick C. Chan. (2013) Demystifying the management of hypertriglyceridaemia. Nature Reviews Cardiology 10:11, pages 648-661.
Crossref
Crossref
Boudewijn Klop, Jan Elte & Manuel Cabezas. (2013) Dyslipidemia in Obesity: Mechanisms and Potential Targets. Nutrients 5:4, pages 1218-1240.
Crossref
Crossref
Migle Baceviciene, Dalia Luksiene, Vida Cesnaitiene, Sandra Raubaite, Anne Peasey & Abdonas Tamosiunas. (2013) Dose-response association between physical activity and metabolic syndrome. Open Medicine 8:2, pages 273-282.
Crossref
Crossref
Myung-A Kim. (2013) Triglyceride and Cardiovascular Disease. Journal of Lipid and Atherosclerosis 2:1, pages 1.
Crossref
Crossref
Caroline SchmidtGöran M.L Bergström. (2012) The Metabolic Syndrome Predicts Cardiovascular Events: Results of a 13-Year Follow-Up in Initially Healthy 58-Year-Old Men. Metabolic Syndrome and Related Disorders 10:6, pages 394-399.
Crossref
Crossref
Niina Matikainen & Marja-Riitta Taskinen. (2012) Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes. Current Cardiology Reports 14:6, pages 721-731.
Crossref
Crossref
Sandra Parra, Gloria Vives, Raimon Ferré, Marta González, Montse Guardiola, Josep Ribalta & Antoni Castro. (2012) Complement system and small HDL particles are associated with subclinical atherosclerosis in SLE patients. Atherosclerosis 225:1, pages 224-230.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Cardiology 27:4, pages 441-454.
Crossref
Crossref
Göran Bergström, CarlJohan Behre & Caroline Schmidt. (2011) Increased Leisure-Time Physical Activity is Associated With Lower Prevalence of the Metabolic Syndrome in 64-Year Old Women With Impaired Glucose Tolerance. Angiology 63:4, pages 297-301.
Crossref
Crossref
A.C.I. Boullart, J. de Graaf & A.F. Stalenhoef. (2012) Serum triglycerides and risk of cardiovascular disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1821:5, pages 867-875.
Crossref
Crossref
Anna Cabré, Nancy Babio, Iolanda Lázaro, Mònica Bulló, Ana Garcia-Arellano, Lluís Masana & Jordi Salas-Salvadó. (2012) FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis 222:1, pages 229-234.
Crossref
Crossref
Guy Cohen, Yael Riahi & Shlomo Sasson. 2012. Encyclopedia of Radicals in Chemistry, Biology and Materials. Encyclopedia of Radicals in Chemistry, Biology and Materials.
Payal Kohli & Christopher P. Cannon. (2012) Triglycerides: How Much Credit Do They Deserve?. Medical Clinics of North America 96:1, pages 39-55.
Crossref
Crossref
Gerald F Watts & Fredrik Karpe. (2011) Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient. Postgraduate Medical Journal 87:1033, pages 776-782.
Crossref
Crossref
Jennifer G. Robinson, Christie M. Ballantyne, Willa Hsueh, Jeffrey Rosen, Jianxin Lin, Arvind Shah, Robert S. Lowe, Mary E. Hanson & Andrew M. Tershakovec. (2011) Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study). Journal of Clinical Lipidology 5:6, pages 474-482.
Crossref
Crossref
Helena J TeedeMarie L MissoAmanda A DeeksLisa J MoranBronwyn G A StuckeyJennifer L A WongRobert J NormanMichael F Costello. (2011) Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline. Medical Journal of Australia 195:S6.
Crossref
Crossref
Gian Paolo Littarru, Luca Tiano, Romualdo Belardinelli & Gerald F. Watts. (2011) Coenzyme Q10, endothelial function, and cardiovascular disease. BioFactors 37:5, pages 366-373.
Crossref
Crossref
M. John Chapman, Henry N. Ginsberg, Pierre Amarenco, Felicita Andreotti, Jan Borén, Alberico L. Catapano, Olivier S. Descamps, Edward Fisher, Petri T. Kovanen, Jan Albert Kuivenhoven, Philippe Lesnik, Luis Masana, Børge G. Nordestgaard, Kausik K. Ray, Zeljko Reiner, Marja-Riitta Taskinen, Lale Tokgözoglu, Anne Tybjærg-Hansen & Gerald F. Watts. (2011) Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. European Heart Journal 32:11, pages 1345-1361.
Crossref
Crossref